Susanne Muller-Knapp

Получаване на мой собствен потребителски профил

Позовавания

	Всички	От 2020
Позовавания	19715	7527
h-индекс	63	47
i10-индекс	123	109

1600

800

400

1200

199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202579 92 162 143 153 174 154 155 182 212 183 217 318 349 312 354 385 471 568 708 942 1467 1366 1453 1403 1559 1499 1394 1418 1364 287

Публичен достъп

Преглед на всички

112 статии

17 статии

налични

неналични

Въз основа на изисквания при финансирането

Съавтори

Oleg FedorovUniversity of OxfordПотвърден имейл адрес: cmd.ox.ac.uk
Panagis FilippakopoulosAssociate Professor, Oxford UniversityПотвърден имейл адрес: sgc.ox.ac.uk
Paul E BrennanUniversity of OxfordПотвърден имейл адрес: cmd.ox.ac.uk
Marco Emilio BianchiSan Raffaele UniversityПотвърден имейл адрес: hsr.it
Wen Hwa LeeAction Against AMD, SGC and University of OxfordПотвърден имейл адрес: actionagainstamd.org
Brian MarsdenCentre for Medicines Discovery & Centre for Human Genetics, NDM, University of OxfordПотвърден имейл адрес: cmd.ox.ac.uk
Benedict-Tilman BergerPostDoc Biochemistry, Goethe University FrankfurtПотвърден имейл адрес: chemie.uni-frankfurt.de
Paola ScaffidiThe Francis Crick InstituteПотвърден имейл адрес: crick.ac.uk
Clarence YappHarvard Medical School, University of OxfordПотвърден имейл адрес: hms.harvard.edu
Apirat ChaikuadПотвърден имейл адрес: pharmchem.uni-frankfurt.de
Chas BountraProfessor of Translational MedicineПотвърден имейл адрес: cmd.ox.ac.uk
Tiziana BonaldiTenured Group Leader European Institute of OncologyПотвърден имейл адрес: ieo.it
Cheryl ArrowsmithSenior Scientist, Princess Margaret Cancer Centre & Professor of Medical Biophysics, University of TorontoПотвърден имейл адрес: uhnres.utoronto.ca
Opher GileadiSGC, Karolinska InstituteПотвърден имейл адрес: ki.se
Andreas KraemerGroup Leader, Structural Genomics ConsortiumПотвърден имейл адрес: pharmchem.uni-frankfurt.de
David Harold DrewryProfessor University of North Carolina Chapel HillПотвърден имейл адрес: unc.edu
anne-claude gingrasLunenfeld-Tanenbaum Research Institute; University of TorontoПотвърден имейл адрес: lunenfeld.ca
Jean-Philippe LambertUniversité LavalПотвърден имейл адрес: crchudequebec.ulaval.ca
Tim WillsonProfessor, UNC Eshelman School of Pharmacy, UNC Chapel HillПотвърден имейл адрес: unc.edu
Frank von DelftPrincipal Investigator: Protein Crystallography, SGC, Oxford UniversityПотвърден имейл адрес: sgc.ox.ac.uk

Следене

Susanne Muller-Knapp

Goethe University Frankfurt

Потвърден имейл адрес: bmls.de - Начална страница

Chemical probes


Заглавие Сортиране по цитати Сортиране по година Сортиране по заглавие	Позовавания Позовавания	Година
Histone recognition and large-scale structural analysis of the human bromodomain family P Filippakopoulos, S Picaud, M Mangos, T Keates, JP Lambert, ... Cell 149 (1), 214-231, 2012	1832	2012
The promise and peril of chemical probes CH Arrowsmith, JE Audia, C Austin, J Baell, J Bennett, J Blagg, C Bountra, ... Nature chemical biology 11 (8), 536-541, 2015	886	2015
Sp1‐mediated transcriptional activation is repressed by Sp3. G Hagen, S Müller, M Beato, G Suske The EMBO journal 13 (16), 3843-3851, 1994	876	1994
HMGB1 is an endogenous immune adjuvant released by necrotic cells P Rovere‐Querini, A Capobianco, P Scaffidi, B Valentinis, F Catalanotti, ... EMBO reports 5 (8), 825-830, 2004	758	2004
Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes G Hagen, S Müller, M Beato, G Suske Nucleic acids research 20 (21), 5519-5525, 1992	720	1992
The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells B Degryse, T Bonaldi, P Scaffidi, S Müller, M Resnati, F Sanvito, ... Journal of Cell Biology 152 (6), 1197-1206, 2001	655	2001
The double life of HMGB1 chromatin protein: architectural factor and extracellular signal S Müller, P Scaffidi, B Degryse, T Bonaldi, L Ronfani, A Agresti, ... The EMBO journal, 2001	588	2001
Bromodomains as therapeutic targets S Muller, P Filippakopoulos, S Knapp Expert reviews in molecular medicine 13, e29, 2011	566	2011
Large-scale structural analysis of the classical human protein tyrosine phosphatome AJ Barr, E Ugochukwu, WH Lee, ONF King, P Filippakopoulos, I Alfano, ... Cell 136 (2), 352-363, 2009	562	2009
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain S Picaud, C Wells, I Felletar, D Brotherton, S Martin, P Savitsky, ... Proceedings of the National Academy of Sciences 110 (49), 19754-19759, 2013	511	2013
Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function S Müller, L Ronfani, ME Bianchi Journal of internal medicine 255 (3), 332-343, 2004	499	2004
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases O Fedorov, B Marsden, V Pogacic, P Rellos, S Müller, AN Bullock, ... Proceedings of the National Academy of Sciences 104 (51), 20523-20528, 2007	422	2007
Exogenous High-Mobility Group Box 1 Protein Induces Myocardial Regeneration After Infarction via Enhanced Cardiac C-Kit⁺ Cell Proliferation and Differentiation F Limana, A Germani, A Zacheo, J Kajstura, A Di Carlo, G Borsellino, ... Circulation research 97 (8), e73-e83, 2005	403	2005
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology P Ciceri, S Müller, A O'mahony, O Fedorov, P Filippakopoulos, JP Hunt, ... Nature chemical biology 10 (4), 305-312, 2014	388	2014
The (un) targeted cancer kinome O Fedorov, S Müller, S Knapp Nature chemical biology 6 (3), 166-169, 2010	378	2010
Comprehensive characterization of the published kinase inhibitor set JM Elkins, V Fedele, M Szklarz, KR Abdul Azeez, E Salah, J Mikolajczyk, ... Nature biotechnology 34 (1), 95-103, 2016	350	2016
Inhibition of BET bromodomain targets genetically diverse glioblastoma Z Cheng, Y Gong, Y Ma, K Lu, X Lu, LA Pierce, RC Thompson, S Muller, ... Clinical cancer research 19 (7), 1748-1759, 2013	345	2013
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains DA Hay, O Fedorov, S Martin, DC Singleton, C Tallant, C Wells, S Picaud, ... Journal of the American Chemical Society 136 (26), 9308-9319, 2014	343	2014
The ins and outs of selective kinase inhibitor development S Müller, A Chaikuad, NS Gray, S Knapp Nature chemical biology 11 (11), 818-821, 2015	302	2015
PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains S Picaud, D Da Costa, A Thanasopoulou, P Filippakopoulos, PV Fish, ... Cancer research 73 (11), 3336-3346, 2013	299	2013

Системата не може да изпълни операцията сега. Опитайте отново по-късно.

Статии 1–20

Позовавания годишно

Дублирани описания

Обединени библиографски описания

Добавяне на съавториСъавтори

Следене

Позовавания

Съавтори